BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37996629)

  • 1. Exploring complexity of class-A Beta-lactamase family using physiochemical-based multiplex networks.
    Bhadola P; Deo N
    Sci Rep; 2023 Nov; 13(1):20626. PubMed ID: 37996629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.
    Drawz SM; Taracila M; Caselli E; Prati F; Bonomo RA
    Protein Sci; 2011 Jun; 20(6):941-58. PubMed ID: 21404358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 4. Variations within class-A β-lactamase physiochemical properties reflect evolutionary and environmental patterns, but not antibiotic specificity.
    Verma D; Jacobs DJ; Livesay DR
    PLoS Comput Biol; 2013; 9(7):e1003155. PubMed ID: 23874193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolutionary Trajectories toward High-Level β-Lactam/β-Lactamase Inhibitor Resistance in the Presence of Multiple β-Lactamases.
    Rajer F; Allander L; Karlsson PA; Sandegren L
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0029022. PubMed ID: 35652643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
    Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
    J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Lactamase inhibitors: an update.
    Chen J; Shang X; Hu F; Lao X; Gao X; Zheng H; Yao W
    Mini Rev Med Chem; 2013 Nov; 13(13):1846-61. PubMed ID: 23895190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
    Gehlot P; P H
    Environ Pollut; 2022 Dec; 314():120289. PubMed ID: 36180000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic substitutions at BLIP position 50 result in changes in binding specificity for class A β-lactamases.
    Adamski CJ; Palzkill T
    BMC Biochem; 2017 Mar; 18(1):2. PubMed ID: 28264645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tackling the Antibiotic Resistance Caused by Class A
    Eiamphungporn W; Schaduangrat N; Malik AA; Nantasenamat C
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic Boronates Inhibit All Classes of β-Lactamases.
    Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactamases and beta-lactamase inhibitors.
    Williams JD
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting functional motifs of a protein family.
    Bhadola P; Deo N
    Phys Rev E; 2016 Oct; 94(4-1):042409. PubMed ID: 27841537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors.
    Salahuddin P; Kumar A; Khan AU
    Curr Protein Pept Sci; 2018; 19(2):130-144. PubMed ID: 28745223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases.
    Caselli E; Powers RA; Blasczcak LC; Wu CY; Prati F; Shoichet BK
    Chem Biol; 2001 Jan; 8(1):17-31. PubMed ID: 11182316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the development of β-lactamase inhibitors.
    Jalde SS; Choi HK
    J Microbiol; 2020 Aug; 58(8):633-647. PubMed ID: 32720096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into structure and activity relationship of clinically mutated PER1 and PER2 class A β-lactamase enzymes.
    Agarwal V; Yadav TC; Tiwari A; Varadwaj PK
    J Biomol Struct Dyn; 2023 Jul; 41(10):4295-4312. PubMed ID: 35475497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories.
    Guthrie VB; Allen J; Camps M; Karchin R
    PLoS Comput Biol; 2011 Sep; 7(9):e1002184. PubMed ID: 21966264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of Beta-lactamases and penicillin binding proteins using ligand-centric network models.
    Öztürk H; Ozkirimli E; Özgür A
    PLoS One; 2015; 10(2):e0117874. PubMed ID: 25689853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between β-lactamases and new β-lactamase inhibitors.
    Bush K; Bradford PA
    Nat Rev Microbiol; 2019 May; 17(5):295-306. PubMed ID: 30837684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.